Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PZ HTL SA
GLOBETECH PUBLISHING LLC

Genetic Barcode Helping Make Sense of Deluge of Genetic Data

By BiotechDaily International staff writers
Posted on 23 Dec 2013
An enhanced internet research application is helping clinicians and cancer researchers make sense out of a flood of genetic data from close to 100,000 patients and more than 50,000 lab mice.

The tool, called the Gene Expression Barcode 3.0, is will be a key resource in the new age of personalized medicine, in which cancer therapies are customized to the genetic composition of an individual patient’s tumor.

Significant new improvements in the Gene Expression Barcode 3.0 were reported in the January 2014 issue of the journal Nucleic Acids Research, published online December 2013 ahead of print. The senior author Dr. Michael J. Zilliox is from the Loyola University Chicago Stritch School of Medicine (IL, USA) and the co-inventor of the Gene Expression Barcode.

“The tool has two main advantages,” Dr. Zilliox said. “It’s fast and it’s free.” The Gene Expression Barcode is available online (please see Related Links below), and designed and hosted by Loyola University Chicago Stritch School of Medicine. The website is receiving 1,600 unique visitors monthly.

Determining how a patient’s cancer genes are expressed can help a clinician put together a pursonlized treatment. In a tumor cell, for example, certain genes are expressed while other genes are unexpressed. Moreover, different kinds of cancer cells have different patterns of gene expression. Genes are expressed through RNA, a nucleic acid that performs as a messenger to carry out instructions from DNA for making proteins.

Research institutions have made public genetic data from nearly 100,000 patients, most of whom had cancer, and more than 50,000 laboratory mice. However, in raw form, these data are too cumbersome to be of much practical use for most researchers. The Gene Expression Barcode employs sophisticated statistical methods to make this huge amount of data much more user-friendly to researchers.

The barcode algorithm is designed to estimate the genes that are expressed and those unexpressed.  The Gene Expression Barcode is binary coded: the expressed genes are ones and the unexpressed genes are zeroes.

Dr. Zilliox co-invented the Gene Expression Barcode, with Rafael Irizarry, Ph.D. Dr. Zilliox and Irizarry first reported the Gene Expression Barcode in 2007. In 2011, they reported an improved 2.0 version. The Barcode already has been cited in more than 120 scientific articles, and the new 3.0 version will make it even easier and faster for researchers to use, according to Dr. Zilliox.

Related Links:

Gene Expression Barcode
Loyola University Chicago Stritch School of Medicine



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: The new peptide offers a triple hormone effect in a single-cell molecule (Photo courtesy of Indiana University).

Tripeptide Drug Effectively Controls Metabolic Syndrome in Rodent Model

Promising results in reducing obesity and normalizing glucose metabolism obtained with a synthetic dipeptide drug have been enhanced by the addition of a molecule of a third hormone, glucagon.... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.